Who's on first in the cellular response to DNA damage?

Nature Reviews Molecular Cell Biology

Volumn 4, Issue 5, 2003, Pages 361-372

  Cline, Susan D ^a   Hanawalt, Philip C ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; RNA POLYMERASE; SPECTRIN; TRANSCRIPTION FACTOR;

DNA DAMAGE; DNA METABOLISM; EXCISION REPAIR; MISMATCH REPAIR; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; DNA; DNA DAMAGE; DNA LIGASES; DNA REPAIR; DNA-BINDING PROTEINS; EUKARYOTIC CELLS; HUMANS; MODELS, BIOLOGICAL; MODELS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 0038557114     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm1101     Document Type: Review

References (150)

1. Lindahl, T. Instability and decay of the primary structure of DNA. Nature 362, 709-715 (1993).
2. Caldecott, K. W. Mammalian DNA single-strand break repair: an X-ra(y)ted affair. Bioessays 23, 447-455 (2001).
3. Haber, J. E. Partners and pathways repairing a double-strand break. Trends Genet. 16, 259-264 (2000).
4. Memisoglu, A. & Samson, L. Base excision repair in yeast and mammals. Mutat. Res. 451, 39-51 (2000).
5. Wood, R. D., Mitchell, M., Sgouros, J. & Lindahl, T. Human DNA repair genes. Science 291, 1284-1289 (2001). A concise review that lists all of the genes that are known to be involved in human DNA-repair mechanisms.
6. Jones, S. et al. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C→T:A mutations. Hum. Mol. Genet. 11, 2961-2967 (2002).
7. Al-Tassan, N. et al. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nature Genet. 30, 227-232 (2002).
8. de Laat, W. L., Jaspers, N. G. & Hoeijmakers, J. H. Molecular mechanism of nucleotide excision repair. Genes Dev. 13, 768-785 (1999).
9. Batty, D. P. & Wood, R. D. Damage recognition in nucleotide excision repair of DNA. Gene 241, 193-204 (2000).
10. Tang, J. Y., Hwang, B. J., Ford, J. M., Hanawalt, P. C. & Chu, G. Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis. Mol. Cell 5, 737-744 (2000).
11. Tornaletti, S. & Hanawalt, P. C. Effect of DNA lesions on transcription elongation. Biochimie 81, 139-146 (1999).
12. Svejstrup, J. Q. Mechanisms of transcription-coupled DNA repair. Nature Rev. Mol. Cell Biol. 3, 21-29 (2002).
13. Marra, G. & Schar, P. Recognition of DNA alterations by the mismatch repair system. Biochem. J. 338, 1-13 (1999).
14. Hsieh, P. Molecular mechanisms of DNA mismatch repair. Mutat. Res. 486, 71-87 (2001).
15. Viswanathan, M., Burdett, V., Baitinger, C., Modrich, P. & Lovett, S. T. Redundant exonuclease involvement in Escherichia cell methyl-directed mismatch repair. J. Biol. Chem. 216, 31053-31058 (2001).
16. Burdett, V., Baitinger, C., Viswanathan, M., Lovett, S. T. & Modrich, P. In vivo requirement for RecJ, ExoVII, ExoI, and ExoX in methyl-directed mismatch repair. Proc Natl Acad. Sci. USA 98, 6765-6770 (2001).
17. Modrich, P. Strand-specific mismatch repair in mammalian cells. J. Biol. Chem. 272, 24727-24730 (1997).
18. Kolodner, R. D. & Marsischky, G. T. Eukaryotic DNA mismatch repair. Curr. Opin. Genet. Dev. 9, 89-96 (1999).
19. 6-alkylguanine by alkyltransferases. Mutat. Res. 462, 83-100 (2000).
20. Duncan, T. et al. Reversal of DNA alkylation damage by two human dioxygenases. Proc. Natl Acad. Sci. USA 99, 16660-16665 (2002).
21. Aas, P. A. et al. Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA. Nature 421, 859-863 (2003).
22. 4MeT from nucleotide excision repair. Carcinogenesis 18, 919-924 (1997).
23. Sitaram, A., Plitas, G., Wang, W. & Scicchitano, D. A. Functional nucleotide excision repair is required for the preferential removal of N-ethylpurines from the transcribed strand of the dihydrofolate reductase gene of Chinese hamster ovary cells. Mol. Cell. Biol. 17, 564-570 (1997).
24. Hickman, M. J. & Samson, L. D. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc. Natl Acad Sci. USA 96, 10764-10769 (1999). This paper shows that repair proteins can also participate in the signalling of apoptosis.
25. Plosky, B. et al. Base excision repair and nucleotide excision repair contribute to the removal of N-methylpurines from active genes. DNA Repair (Amst.) 1, 683-696 (2002).
26. Sancar, G. B. Enzymatic photoreactivation: 50 years and counting. Mutat. Res. 451, 25-37 (2000).
27. Sancar, A., Franklin, K. A. & Sancar, G. B. Escherichia coli DNA photolyase stimulates uvrABC excision nuclease in vitro. Proc. Natl Acad. Sci. USA 81, 7397-7401 (1984). The first report that a DNA-damage-recognition protein outside of an excision repair pathway could affect repair of the damage by the excision repair mechanism.
28. Sancar, G. B. & Smith, F. W. Interactions between yeast photolyase and nucleotide excision repair proteins in Saccharomyces cerevisiae and Escherichia coli. Mol. Cell. Biol. 9, 4767-4776 (1989).
29. Livingstone-Zatchej, M., Meier, A., Suter, B. & Thoma, F. RNA polymerase II transcription inhibits DNA repair by photolyase in the transcribed strand of active yeast genes. Nucleic Acids Res. 25, 3795-3800 (1997).
30. Aboussekhra, A. & Thoma, F. Nucleotide excision repair and photolyase preferentially repair the nontranscribed strand of RNA polymerase III-transcribed genes in Saccharomyces cerevisiae. Genes Dev. 12, 411-421 (1998).
31. Suter, B., Livingstone-Zatchej, M. & Thoma, F. Chromatin structure modulates DNA repair by photolyase in vivo. EMBO J. 16, 2150-2160 (1997).
32. Sebastian, J. & Sancar, G. B. A damage-responsive DNA binding protein regulates transcription of the yeast DNA repair gene PHR1. Proc. Natl Acad. Sci USA 88, 11251-11255 (1991).
33. Iben, S. et al. TFIIH plays an essential role in RNA polymerase I transcription. Cell 109, 297-306 (2002).
34. Flores, O., Lu, H. & Reinberg, D. Factors involved in specific transcription by mammalian RNA polymerase II. Identification and characterization of factor IIH. J. Biol. Chem. 267, 2786-2793 (1992).
35. Erdile, L. F., Heyer W. D., Kolodner, R. & Kelly, T. J. Characterization of a cDNA encoding the 70-kDa single-stranded DNA-binding subunit of human replication protein A and the role of the protein in DNA replication. J. Biol. Chem. 266, 12090-12098 (1991).
36. Mellon, I., Rajpal, D. K., Koi, M., Boland, C. R. & Champe, G. N. Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Science 272, 557-560 (1996).
37. Mellon, I. & Champe, G. N. Products of DNA mismatch repar genes mutS and mutL are required for transcription-coupled nucleotide-excision repair of the lactose operon in Escherichia coli. Proc. Natl Acad Sci. USA 93, 1292-1297 (1996). References 36 and 37 present the discovery of 'crosstalk' between DNA-damage excision repair pathways.
38. Leadon, S. A. & Avrutskaya, A. V. Differential involvement of the human mismatch repair proteins, hMLH1 and hMSH2, in transcription-coupled repair. Cancer Res. 57, 3784-3791 (1997).
39. Conconi, A., Bespalov, V. A. & Smerdon, M. J. Transcription-coupled repair in RNA polymerase I-transcribed genes of yeast. Proc. Natl Acad. Sci. USA 99, 649-654 (2002).
40. Perlow, R. A. et al. DNA adducts from a tumorigenic metabolite of benzo[a]pyrene block human RNA polymerase II elongation in a sequence- and stereochemistry-dependent manner. J. Mol. Biol. 321, 29-47 (2002).
41. Tornaletti, S., Donahue, B. A., Reines, D. & Hanawalt, P. C. Nucleotide sequence context effect of a cyclobutane pyrimidine dimer upon RNA polymerase II transcription. J. Biol. Chem. 272, 31719-31724 (1997).
42. Christians, F. C. & Hanawalt, P. C. Lack of transcription-coupled repair in mammalian ribosomal RNA genes Biochemistry 32, 10512-10518 (1993).
43. Dammann, R. & Pfeifer, G. P. Lack of gene- and strand- specific DNA repair in RNA polymerase III-transcribed human tRNA genes. Mol. Cell. Biol. 17, 219-229 (1997).
44. Ljungman, M., Zhang, F., Chen, F., Rainbow, A. J. & McKay, B. C. Inhibition of RNA polymerase II as a trigger for the p53 response. Oncogene 18, 583-592 (1999).
45. Wold, M. S. Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism. Annu. Rev. Biochem. 66, 61-92 (1997).
46. Lao, Y., Lee, C. G. & Wold, M. S. Replication protein A interactions with DNA. 2. Characterization of double-stranded DNA-binding/helix-destabilization activities and the role of the zinc-finger domain in DNA interactions. Biochemistry 38, 3974-3984 (1999).
47. Clugston, C. K., McLaughlin, K., Kenny, M. K. & Brown, R. Binding of human single-stranded DNA binding protein to DNA damaged by the anticancer drug cis-diamminedichloroplatinum (II). Cancer Res. 52, 6375-6379 (1992).
48. Turchi, J. J., Henkels, K. M., Hermanson, I. L. & Patrick, S. M. Interactions of mammalian proteins with cisplatin-damaged DNA. J. Inorg. Biochem. 77, 83-87 (1999).
49. Patrick, S. M. & Turchi, J. J. Human replication protein A preferentially binds cisplatin-damaged duplex DNA in vitro. Biochemistry 37, 8808-8815 (1998).
50. Reardon, J. T. & Sancar, A. Molecular anatomy of the human excision nuclease assembled at sites of DNA damage. Mol. Cell. Biol. 22, 5938-5945 (2002).
51. He, Z., Henricksen, L. A., Wold, M. S. & Ingles, C. J. RPA involvement in the damage-recognition and incision steps of nucleotide excision repair. Nature 374, 566-569 (1995).
52. Bums, J. L., Guzder, S. N., Sung, P., Prakash, S. & Prakash, L. An affinity of human replication protein A for ultraviolet-damaged DNA. J. Biol. Chem. 271, 11607-11610 (1996).
53. Lao, Y., Games, X. V., Ren, Y., Taylor, J. S. & Wold, M. S. & Wold, M. S. Replication protein A interactions with DNA. III. Molecular basis of recognition of damaged DNA. Biochemistry 39, 850-859 (2000).
54. Evans, E., Moggs, J. G., Hwang, J. R., Egly, J. M. & Wood, R. D. Mechanism of open complex and dual incision formation by human nucleotide excision repair factors. EMBO J. 16, 6559-6573 (1997).
55. Mu, D., Wakasugi, M., Hsu, D. S. & Sancar, A. Characterization of reaction intermediates of human excision repair nuclease. J. Biol. Chem. 272, 28971-28979 (1997).
56. de Laat, W. L. et al. DNA-binding polarity of human replication protein A positions nucleases in nucleotide excision repair. Genes Dev. 12, 2598-2609 (1998).
57. Mer, G. et al. Structural basis for the recognition of DNA repair proteins UNG2, XPA, and RAD52 by replication factor RPA. Cell 103, 449-456 (2000).
58. Wang, H., Lawrence, C. W., Li, G. M. & Hays, J. B. Specific binding of human MSH2. MSH6 mismatch-repair protein heterodimers to DNA incorporating thymine- or uracil-containing UV light photoproducts opposite mismatched bases. J. Biol. Chem. 274, 16894-16900 (1999).
59. Ni, T. T., Marsischky, G. T. & Kolodner, R. D. MSH2 and MSH6 are required for removal of adenine misincorporated opposite 8-oxo-guanine in S. cerevisiae. Mol. Cell 4, 439-444 (1999).
60. 4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl Acad. Sci. USA 93, 6443-6447 (1996).
61. Mello, J. A., Acharya, S., Fishel, R. & Essigmann, J. M. The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem. Biol. 3, 579-589 (1996).
62. Swann, P. F. et al. Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science 273, 1109-1111 (1996).
63. Kat, A. et al. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc. Natl. Acad. Sci. USA 90, 6424-6428 (1993).
64. Huang, J. C., Hsu, D. S., Kazantsev, A. & Sancar, A. Substrate spectrum of human excinuclease: repair of abasic sites, methylated bases, mismatches, and bulky adducts. Proc. Natl Acad. Sci. USA 91, 12213-12217 (1994).
65. 6-methylguanine by ABC excinuclease of Escherichia coli in vitro. J. Biol. Chem. 264, 5172-5176 (1989).
66. Johnson, K. A., Mierzwa, M. L., Fink, S. P. & Marnett, L. J. MutS recognition of exocyclic DNA adducts that are endogenous products of lipid oxidation. J. Biol. Chem. 274, 27112-27118 (1999).
67. Johnson, K. A., Fink, S. P. & Marnett, L. J. Repair of propanodeoxyguanosine by nucleotide excision repair in vivo and in vitro. J. Biol. Chem. 272, 11434-11438 (1997).
68. Gu, Y. et al. Human MutY homolog, a DNA glycosylase involved in base excision repair, physically and functionally interacts with mismatch repair proteins human MutS homolog 2/human MutS homolog 6. J. Biol. Chem. 277, 11135-11142 (2002).
69. Meira, L. B. et al. Mice defective in the mismatch repair gene Msh2 show increased predisposition to UVB radiation-induced skin cancer. DNA Repair (Amst,) 1, 929-934 (2002).
70. Bertrand, P., Tishkoff, D. X., Filosi, N., Dasgupta, R. & Kolodner, R. D. Physical interaction between components of DNA mismatch repair and nucleotide excision repair. Proc. Natl. Acad. Sci. USA 95, 14278-14283 (1998). This paper shows the interaction between yeast MSH2 and NER proteins, and provides support for the model of MMR protein assistance in the repair of UV-induced DNA damage.
71. Kartalou, M. & Essigmann, J. M. Recognition of cisplatin adducts by cellular proteins. Mutat. Res. 478, 1-21 (2001). A comprehensive review that discusses the interaction of HMG-domain proteins and other cellular factors with cisplatin-induced DNA damage, and the effect of these interactions on DNA repair and the normal cellular functions of these proteins.
72. Bustin, M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol. Cell Biol. 19, 5237-5246 (1999).
73. Kim, J. L., Nikolov, D. B. & Burley, S. K. Co-crystal structure of TBP recognizing the minor groove of a TATA element. Nature 365, 520-527 (1993).
74. Ohndorf, U. M., Rould, M. A., He, Q., Pabo, C. O. & Lippard, S. J. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Nature 399, 708-712 (1999).
75. Takahara, P. M., Rosenzweig, A. C., Fredenck, C. A. & Lippard, S. J. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Nature 377, 649-652 (1995).
76. Huang, J. C., Zamble, D. B., Reardon, J. T., Lippard, S. J. & Sancar, A. HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease. Proc. Natl Acad. Sci. USA 91, 10394-10398 (1994).
77. Zamble, D. B., Mu, D., Reardon, J. T., Sancar, A. & Lippard, S. J. Repair of cisplatin-DNA adducts by the mammalian excision nuclease. Biochemistry 35, 10004-10013 (1996).
78. Trimmer, E. E., Zamble, D. B., Lippard, S. J. & Essigmann, J. M. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities. Biochemistry 37, 352-362 (1998).
79. McA'Nulty, M. M., Whitehead, J. P. & Lippard, S. J. Binding of lxr1, a yeast HMG-domain protein, to cisplatin-DNA adducts in vitro and in vivo. Biochemistry 35, 6089-6099 (1996).
80. McA'Nulty M. M. & Lippard, S. J. The HMG-domain protein lxr1 blocks excision repair of cisplatin-DNA adducts in yeast. Mutat. Res. 362, 75-86 (1996).
81. Brown, S. J., Kellett, P. J. & Lippard, S. J. lxr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin. Science 261, 503-605 (1993).
82. Paull, T. T., Carey, M. & Johnson, R. C. Yeast HMG proteins NHP6A/B potentiate promoter-specific transcriptional activation in vivo and assembly of preinitiation complexes in vitro. Genes Dev. 10, 2769-2781 (1996).
83. Kruppa, M., R. D., Kolodrubetz, D. & Willis, I. M. Nhp6, an HMG1 protein, functions in SNR6 transcription by RNA polymerase III in S. cerevisiae. Mol. Cell 7, 309-318 (2001).
84. Didier, D. K., Schiffenbauer, J., Woulfe, S. L., Zacheis, M. & Schwartz, B. D. Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proc. Natl Acad. Sci. USA 85, 7322-7326 (1988).
85. Ohga, T. et al. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res. 56, 4224-4228 (1996).
86. Ise, T. et al. Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. Cancer Res. 59, 342-346 (1999).
87. Wong, B. et al. Binding to cisplatin-modified DNA by the Saccharomyces cerevisiae HMGB protein Nhp6A. Biochemistry 41, 5404-5414 (2002).
88. Treiber, D. K., Zhai, X., Jantzen, H. M. & Essigmann, J. M. Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor). Proc. Natl Acad. Sci. USA 91, 5672-5676 (1994).
89. Jordan, P. & Carmo-Fonseca, M. Cisplatin inhibits synthesis of ribosomal RNA in vivo. Nucleic Acids Res. 26, 2831-2836 (1998).
90. Zhai, X., Beckmann, H., Jantzen, H. M. & Essigmann, J. M. Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor. Biochemistry 37, 16307-16315 (1998). This paper verifies the model of transcription-factor 'hijacking' that is proposed in reference 88, and shows that DNA-damage recognition by cellular proteins can have important repercussions on both repair and the normal functions of the proteins.
91. Jung, Y., Mikata, Y. & Lippard, S. J. Kinetic studies of the TATA-binding protein interaction with cisplatin-modified DNA. J. Biol. Chem. 276, 43589-43596 (2001).
92. Vichi, P. et al. Cisplatin- and UV-damaged DNA lure the basal transcription factor TFIID/TBP. EMBO J. 16, 7444-7456 (1997).
93. Brand, M. et al. UV-damaged DNA-binding protein in the TFTC complex links DNA damage recognition to nucleosome acetylation. EMBO J. 20, 3187-3196 (2001).
94. Yaneva, J., Leuba, S. H., van Holde, K. & Zlatanova, J. The major chromatin protein histone H1 binds preferentially to cis-platinum-damaged DNA. Proc Natl Acad. Sci. USA 94, 13448-13451 (1997).
95. D'Andrea, A. D. & Grompe, M. The Fanconi anaemia/BRCA pathway. Nature Rev. Cancer 3, 23-34 (2003). The most up-to-date review of FA protein interactions and evidence for their involvement in a novel repair pathway for interstrand DNA cross-links.
96. Dronkert, M. L. & Kanaar, R. Repair of DNA interstrand cross-links. Mutat. Res. 486, 217-247 (2001).
97. Van Houten, B. Nucleotide excision repair in Escherichia coli. Microbiol. Rev. 54, 18-51 (1990).
98. Cheng, N. C. et al. Mice with a targeted disruption of the Fanconi anemia homolog Fanca. Hum. Mol. Genet. 9, 1805-1811 (2000).
99. Chen, M. et al. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nature Genet. 12, 448-451 (1996).
100. Koomen, M. et al. Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice Hum. Mol. Genet. 11, 273-281 (2002).
101. Garcia-Higuera, I., Kuang, Y., Naf, D., Wasik, J. & D'Andrea, A. D. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol. Cell. Biol. 19, 4866-4873 (1999).
102. de Winter, J. P. et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum. Mol. Genet. 9, 2665-2674 (2000). This paper shows the accumulation and assembly of FA proteins into a nuclear complex in human cells, and supports the model for a DNA-damage response pathway involving these proteins.
103. Garcia-Higuera, I., Kuang, Y., Denham, J. & D'Andrea, A. D. The Fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex. Blood 96, 3224-3230 (2000).
104. Kumaresan, K. R. & Lambert, M. W. Fanconi anemia, complementation group A, cells are defective in ability to produce incisions at sites of psoralen interstrand cross-links. Carcinogenesis 21, 741-751 (2000).
105. McMahon, L. W., Sangerman, J., Goodman, S. R., Kumaresan, K. & Lambert, M. W. Human α-spectrin II and the FANCA, FANCC, and FANCG proteins bind to DNA containing psoralen interstrand cross-links. Biochemistry 40, 7025-7034 (2001).
106. McMahon, L. W., Walsh, C. E. & Lambert, M. W. Human α-spectrin II and the Fanconi anemia proteins FANCA and FANCC interact to form a nuclear complex. J. Biol. Chem. 274, 32904-32908 (1999).
107. Otsuki, T. et al. Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex. Hum. Mol. Genet, 10, 2651-2660 (2001).
108. Pace, P. et al. FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J. 21, 3414-3423 (2002).
109. Grompe, M. FANCD2: a branch-point in DNA damage response? Nature Med. 8, 555-556 (2002).
110. Folias, A. et al. BRCA1 interacts directly with the Fanconi anemia protein FANCA. Hum. Mol. Genet, 11, 2591-2597 (2002).
111. Garcia-Higuera, I. et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7, 249-262 (2001). This paper presents evidence for a unique FA pathway that responds to DNA damage caused by cross-linking agents, in which the signal for DNA repair involves the monoubiquitylation of FANCD2 and its association with BRCA1 in nuclear foci.
112. Moynahan, M. E., Cui, T. Y. & Jasin, M. Homology-directed DNA repair, mitomycin-C resistance, and chromosome stability is restored with correction of a Brcal mutation. Cancer Res. 61, 4842-4850 (2001).
113. Abraham, R. T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15, 2177-2196 (2001).
114. Cliby, W. A. et al. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J. 17, 159-169 (1998).
115. Unsal-Kacmaz, K., Makhov, A. M., Griffith, J. D. & Sancar, A. Preferential binding of ATR protein to UV-damaged DNA. Proc. Natl Acad Sci. USA 99, 6673-6678 (2002).
116. Lupardus, P. J., Byun, T., Yee, M. C., Hekmat-Nejad, M. & Cimprich, K. A. A requirement for replication in activation of the ATR-dependent DNA damage checkpoint. Genes Dev. 16, 2327-2332 (2002).
117. Paciotti, V., Clerici, M., Lucchini, G. & Longhese, M. P. The checkpoint protein Ddc2, functionally related to S. pombe Rad26, interacts with Mec1 and is regulated by Mec1-dependent phosphorylation in budding yeast. Genes Dev. 14, 2046-2059 (2000).
118. Melo, J. A., Cohen, J. & Toczyski, D. P. Two checkpoint complexes are independently recruited to sites of DNA damage in vivo. Genes Dev. 15, 2809-2821 (2001).
119. Pommier, Y., Pourquier, P., Fan, Y. & Strumberg, D. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim. Biophys. Acta 1400, 83-105 (1998).
120. Fortune, J. M. & Osheroff, N. Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. Prog Nucleic Acid Res. Mol. Biol. 64, 221-253 (2000).
121. Hsiang, Y. H., Lihou, M. G. & Liu, L. F. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res. 49, 5077-5082 (1989).
122. Tsao, Y. P., Russo, A., Nyamuswa, G., Silber, R. & Liu, L. F. Interaction between replication forks and topoisomerase I- DNA cleavable complexes: studies in a cell-free SV40 DNA replication system. Cancer Res 53, 5908-5914 (1993).
123. Strumberg, D. et al. Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5′-phosphorylated DNA double-strand breaks by replication runoff. Mol. Cell. Biol. 20, 3977-3987 (2000).
124. Bendixen, C., Thomsen, B., Alsner, J. & Westergaard, O. Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription. Biochemistry 29, 8613-8619 (1990).
125. Wu, J. & Liu, L. F. Processing of topoisomerase I cleavable complexes into DNA damage by transcription. Nucleic Acids Res. 25, 4181-4186 (1997). This paper shows an increase in Top1-linked DNA breaks in human fibroblasts after exposure to UV, and is the first evidence of a cellular response by topoisomerases to the induction of DNA damage.
126. Kingma, P. S. & Osheroff, N. The response of eukaryotic topoisomerases to DNA damage. Biochim. Biophys. Acta 1400, 223-232 (1998).
127. Subramanian, D., Rosenstein, B. S. & Muller, M. T. Ultraviolet-induced DNA damage stimulates topoisomerase I-DNA complex formation in vivo: possible relationship with DNA repair. Cancer Res. 58, 976-984 (1998).
128. Pommier, Y. et al. Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages. Proc. Natl Acad. Sci. USA 97, 2040-2045 (2000).
129. Pourquier, P. et al. Induction of topoisomerase I cleavage complexes by 1-β-D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells. Proc. Natl Acad. Sci. USA 97, 1885-1890 (2000).
130. Pourquier, P. et al. Gemcitabine (2′,2′-difluoro-2′-deoxycytidine), an antimetabolite that poisons topoisomerase I. Clin. Cancer Res 8, 2499-2504 (2002).
131. Stevnsner, T., Mortensen, U. H., Westergaard, O. & Bonven, B. J. Interactions between eukaryotic DNA topoisomerase I and a specific binding sequence. J. Biol. Chem. 264, 10110-10113 (1989).
132. Thomsen, B. et al. Characterization of the interaction between topoisomerase II and DNA by transcriptional footprinting. J. Mol. Biol. 215, 237-244 (1990).
133. Nitiss, J. L., Nitiss, K. C., Rose, A. & Waltman, J. L. Overexpression of type I topoisomerases sensitizes yeast cells to DNA damage. J. Biol. Chem. 276, 26708-26714 (2001).
134. Chakraverty, R. K. et al. Topoisomerase III acts upstream of Rad53p in the S-phase DNA damage checkpoint. Mol. Cell. Biol. 21, 7150-7162 (2001). This study shows the involvement of Top3 in the S-phase DNA-damage checkpoint of yeast, and is the first evidence for a physiological role for a topoisomerase enzyme in a DNA-damage response pathway.
135. Li, T. K. et al. Activation of topoisomerase II-mediated excision of chromosomal DNA loops during oxidative stress. Genes Dev. 13, 1553-1560 (1999).
136. Lagarkova, M. A., Iarovaia, O. V. & Razin, S. V. Large-scale fragmentation of mammalian DNA in the course of apoptosis proceeds via excision of chromosomal DNA loops and their oligomers. J. Biol Chem. 270, 20239-20241 (1995).
137. Cline, S. D., Jones, W. R., Stone, M. P. & Osheroff, N. DNA abasic lesions in a different light: solution structure of an endogenous topoisomerase II poison. Biochemistry 38, 15500-15507 (1999).
138. Sabounn, M. & Osheroff, N. Sensitivity of human type II topoisomerases to DNA damage: stimulation of enzyme-mediated DNA cleavage by abasic, oxidized and alkylated lesions. Nucleic Acids Res. 28, 1947-1954 (2000).
139. Wilstermann, A. M., & Osheroff, N. Base excision repair intermediates as topoisomerase II poisons. J. Biol. Chem. 276, 46290-46296 (2001).
140. Pourquier, P. et al. Induction of reversible complexes between eukaryotic DNA topoisomerase I and DNA-containing oxidative base damages 7, 8-dihydro-8-oxoguanine and 5-hydroxycytosine J. Biol. Chem. 274, 8516-8523 (1999).
141. 6-methylguanine. Cancer Res. 61, 53-58 (2001).
142. 6-ethenoadenine. J. Biol. Chem. 273, 27245-27249 (1998).
143. Lanza, A., Tornaletti, S., Rodoffo, C., Scanavini, M. C. & Pedrini, A. M. Human DNA topoisomerase I-mediated cleavages stimulated by ultraviolet light-induced DNA damage. J Biol. Chem. 271, 6978-6986 (1996).
144. Corbett, A. H., Zechiedrich, E. L., Lloyd, R. S. & Osheroff, N. Inhibition of eukaryotic topoisomerase II by ultraviolet-induced cyclobutane pyrimidine dimers. J Biol. Chem. 266, 19666-19671 (1991).
145. Pommier, Y. et al. Position-specific trapping of topoisomerase I-DNA cleavage complexes by intercalated benzo[a]-pyrene diol epoxide adducts at the 6-amino group of adenine. Proc. Natl Acad. Sci. USA 97, 10739-10744 (2000).
146. Pourquier, P. et al. Trapping of mammalian topoisomerase I and recombination induced by damaged DNA containing nicks or gaps. Importance of DNA end phosphorylation and camptothecin effects. J. Biol. Chem. 272, 26441-26447 (1997).
147. Wang, Y., Knudsen, B. R., Bjergbaek, L., Westergaard, O. & Andersen, A. H. Stimulated activity of human topoisomerases IIα and IIβ on RNA-containing substrates. J. Biol. Chem. 274, 22839-22846 (1999).
148. Wang, Y., Thyssen, A., Westergaard, O. & Andersen, A. H. Position-specific effect of dbonucleotides on the cleavage activity of human topoisomerase II. Nucleic Acids Res. 28, 4815-4821 (2000).
149. Cline, S. D. & Osheroff, N. Cytosine arabinoside lesions are position-specific topoisomerase II poisons and stimulate DNA cleavage mediated by the human type II enzymes J. Biol. Chem. 274, 29740-29743 (1999).
150. Perrino, F. W. Miller, H. & Ealey, K. A. Identification of a 3′→5′-exonuclease that removes cytosine arabinoside monophosphate from 3′ termini of DNA. J. Biol. Chem. 269, 16357-16363 (1994).